Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors

0
199
Ruth Williams-Brinkley

AUSTIN, Texas– Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that Ruth E. Williams-Brinkley has been appointed to the Company’s board of directors.

Williams-Brinkley has three decades of healthcare industry experience. She currently serves as president of Kaiser Permanente Health Plan of the Mid-Atlantic States (KPMAS), where she oversees the company’s care delivery and health plan operations in Washington, D.C., suburban Maryland, Baltimore, and Northern Virginia. KPMAS serves nearly 830,000 members, operates more than 35 medical office buildings, and maintains partnerships with 11 premier hospitals and health systems in the region.

“Ruth is an accomplished healthcare leader and an extraordinary individual who will be an outstanding complement to our board,” said Steve Chapman, Natera’s chief executive officer. “We are thrilled to welcome Ruth to Natera and look forward to drawing on her deep knowledge and professional experience as a seasoned healthcare executive.”

The appointment of Williams-Brinkley, which is effective as of March 2, 2023, will expand the Natera board to ten directors.

Prior to her current role, Williams-Brinkley was president of Kaiser Permanente Health Plan and Hospitals of the Northwest. She also previously served as the inaugural CEO of KentuckyOne Health, which was the largest integrated health system in Kentucky; president and CEO of Carondelet Health System in Tucson, Arizona; and president and CEO of Memorial Healthcare System in Chattanooga, Tennessee.

“I am delighted to have the opportunity to join the Natera board at such an exciting time in the Company’s evolution,” said Williams-Brinkley. “Natera has an impressive portfolio of established products primed to address unmet clinical needs in oncology, women’s health and organ health. I am inspired to help advance the Company’s mission together with the board and leadership team.”

Williams-Brinkley serves on the boards of Travere Therapeutics, DePaul University, the Greater Washington Board of Trade, and the Northern Virginia Trade of Commerce. She obtained a bachelor’s degree and Master of Science degree, both in nursing from DePaul University. (IANS)